ABSTRACT Background: Sub-Saharan Africa is facing a double burden of malnutrition: vitamin A deficiency (VAD) prevails, whereas the nutrition-related chronic conditions type 2 diabetes (T2D) and hypertension are emerging. Serum retinol-a VAD marker-increases in kidney disease and decreases in inflammation, which can partly be attributed to alterations in the vitamin A-transport proteins retinolbinding protein 4 (RBP4) and prealbumin. Kidney dysfunction and inflammation commonly accompany T2D and hypertension. Objective: Among urban Ghanaians, we investigated the associations of T2D and hypertension with serum retinol as well as the importance of kidney function and inflammation in this regard. Design: A hospital-based, case-control study in individuals for risk factors of T2D, hypertension, or both was conducted in Kumasi, Ghana (328 controls, 197 with T2D, 354 with hypertension, and 340 with T2D plus hypertension). In 1219 blood samples, serum retinol, RBP4, and prealbumin were measured. Urinary albumin and estimated glomerular filtration rate (eGFR) defined kidney function. C-reactive protein (CRP) .5 mg/L indicated inflammation. We identified associations of T2D and hypertension with retinol by linear regression and calculated the contribution of RBP4, prealbumin, urinary albumin, eGFR, and CRP to these associations as the percentages of the explained variance of retinol. Results: VAD (retinol ,1.05 mmol/L) was present in 10% of this predominantly female, middle-aged, overweight, and deprived population. Hypertension, but not T2D, was positively associated with retinol (b: 0.12; 95% CI: 0.08, 0.17), adjusted for age, sex, socioeconomic factors, anthropometric measurements, and lifestyle. In addition to RBP4 (72%) and prealbumin (22%), the effect of increased retinol on individuals with hypertension was mainly attributed to impaired kidney function (eGFR: 30%; urinary albumin: 5%) but not to inflammation. Conclusions: In patients with hypertension, VAD might be underestimated because of increased serum retinol in the context of kidney dysfunction. Thus, the interpretation of serum retinol in sub-Saharan Africa should account for hypertension status.
INTRODUCTION
Vitamin A deficiency (VAD) 6 is a global problem, affecting one-third of preschool-aged children and 15% of pregnant women (1) . VAD causes embryonic malformations, retarded growth, weakened immunity, and impaired vision (2) . Africa has the highest prevalence of VAD-associated night blindness among preschool-aged children (2.0%), which corresponds to almost half of the children affected globally; .3 million pregnant women in the African region suffer from VAD-associated blindness (1) . At the same time, sub-Saharan Africa is facing an enormous increase in noncommunicable diseases (NCDs), including type 2 diabetes (T2D), hypertension, and cardiovascular disease. One in four deaths in this region occurs because of NCDs (3) . With regard to diabetes, the number of affected individuals is projected to double from 20 million to 42 million by 2035 (4) . Hypertension in Africa affects more than one-quarter of the adult population (5) , and in this region, rates of increase in hypertension are among the highest worldwide (6) .
Despite the emerging double burden of VAD and NCDs in subSaharan Africa, the role of serum retinol as a VAD marker in individuals with T2D and hypertension has not been verified, particularly when taking into account the increased burden of kidney dysfunction and chronic inflammation (7, 8) . In fact, kidney dysfunction and inflammation influence vitamin A metabolism: the major extracellular transport protein of retinol is retinol-binding protein 4 (RBP4). After retinol-RBP4 formation in the liver, this complex further binds to prealbumin. During inflammation, the hepatic synthesis and secretion of RBP4 and prealbumin decline (2) , resulting in reduced serum retinol concentrations. In contrast, in kidney dysfunction, renal retention of the retinol-RBP4-prealbumin complex might be enhanced, and serum retinol concentrations increase. Renal retention may also stimulate hepatic retinol secretion due to distraction of regulatory feedback mechanisms (9) . Kidney function thus is essential in appraising retinol concentrations, and in the interpretation of related findings-that is, it strongly influences the association of RBP4 with markers of insulin resistance (10) (11) (12) (13) .
In the present study, we aimed at investigating the relations of T2D and hypertension with serum retinol for the assessment of VAD in an adult Ghanaian population. We examined whether or not kidney dysfunction and inflammation account for the potential associations of T2D and hypertension with retinol concentrations, in addition to the major vitamin A-transport proteins RBP4 and prealbumin.
METHODS

Study population and design
The Kumasi Diabetes and Hypertension Study was conducted as an unmatched case-control study at Komfo Anokye Teaching Hospital, Kumasi, Ghana, from August 2007 through June 2008. Details of the study site and recruitment procedures are provided elsewhere (14) . Briefly, study participants were recruited among patients attending the diabetes center and the hypertension clinic of the hospital. These patients encouraged their neighbors, friends, and community members to participate as controls (blood collection and biomarker measurements, see below). In addition, preliminary controls came from the outpatient department and hospital staff. The final study population comprised 1219 participants. Figure 1 presents a flow diagram of excluded participants with missing or implausible data. The study protocol was reviewed and approved by the Ethics Committee of the School of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, and was in accordance with the Declaration of Helsinki. All participants gave written informed consent. Inclusion criteria were age $18 y, permanent residence in Kumasi, and self-reported Akan ethnicity. We excluded individuals with known liver cirrhosis, who were currently pregnant, and with conflicting self-reported disease status.
All participants were instructed on fasting; abstaining from alcohol, coffee, and cigarette smoking; and avoiding vigorous physical activity from 2200 h of the day before the examination. On the examination day, the participants underwent a routine clinical examination, provided fasting blood and urine samples, and reported their medical history, including information on drug intake and smoking behavior. Self-reported socioeconomic data were documented. Trained nurses measured weight (kg) by a person scale, height (cm) by a stadiometer, and waist and hip circumferences (cm) by a measuring tape (all devices, Seca). BMI was calculated as weight divided by height squared (kg/m 2 ). We defined overweight as having a BMI (in kg/m 2 ) from 25.0 to ,30.0 and obesity as having a BMI $30.0. Waist-to-hip ratio was computed as waist circumference divided by hip circumference. Systolic and diastolic blood pressures (mm Hg) were assessed with appropriate cuffs after 10 min of resting time on a comfortable chair in an air-conditioned room at 0, 5, and 10 min (M8 Comfort; Omron). Hypertension was defined as having a mean blood pressure $140/90 mm Hg or taking documented antihypertensive treatment.
Blood collection and biomarker measurements
Fasting blood samples were collected into fluoride and serum tubes. In fluoride whole blood, fasting plasma glucose was measured immediately after blood collection by photometry (Glucose 201+ Analyzer; HemoCue) in the air-conditioned study laboratory. Glucose concentration is presented as plasma equivalents. The interassay CV ranged between 1.7% and 6.1%. T2D was defined as having fasting plasma glucose $7 mmol/L or taking documented antidiabetic medication. Serum tubes were centrifuged at 6400 g for 10 min, and aliquots were frozen at 2208C. On dry ice, samples were transferred to the German Institute of Human Nutrition Potsdam-Rehbruecke, where triglycerides (mmol/L) and total cholesterol (mmol/L) were measured by colorimetric assays (ABX Pentra400; Horiba Medical). The interassay CVs were 4.5% and 3.0%, respectively. Serum creatinine was quantified by a kinetic test, applying the Jaffé method (ABX Pentra400; Horiba Medical; interassay CV: 4.3%). The estimated glomerular filtration rate (eGFR; mL/ min per 1.73 m 2 ) was calculated by using the abbreviated Modification of Diet in Renal Disease formula on the basis of age, sex, and serum creatinine: 186 3 (creatinine in mg/dL) 21 (17) . For the quantifications of RBP4, we applied a noncommercial ELISA (18) using horseradish peroxidase-conjugated polyclonal rabbit-anti-human retinolbinding protein antibody diluted 1:200 for detection (Immunodiagnostik). In addition, samples were applied at 100 mL/ well and all incubation times were extended to 90 min. Prealbumin was measured by ELISA by using a protocol as previously described (13, 19) .
Intake of vitamin A-rich foods
Vitamin A status is influenced by the intake of vitamin A-rich foods (20) . Thus, we assessed food intake by means of a Ghanaspecific food-frequency questionnaire (FFQ) and a single 24-h dietary recall (21) . In brief, trained nurses conducted face-toface interviews in an air-conditioned room after breakfast. The FFQ queried for the intake frequency of 51 food items during the past 12 mo in 6 response categories: never, seldom (,1 time/wk), 1-2 times/wk, 3-4 times/wk, 5-6 times/wk, and daily. No portion sizes were available, and the FFQ is not yet validated in this population. With regard to the 24-h dietary recall, all foods and beverages consumed between midnight of the second to last day and midnight of the last day were documented in detail. We recorded time and occasion of the meals, their mode of preparation, and their portion sizes, estimated by common Ghanaian household utensils.
Statistical analyses
Energy intake (kcal/d) and the contribution of macronutrients to energy intake (% of energy) were derived from the recall data. The estimated portion sizes were converted into grams (22) , and Ghana-specific nutrient-composition tables were used to translate the consumed foods into nutrient intake (23) . Daily intake frequencies of 15 food items rich in vitamin A or pro-vitamin A were determined from the FFQ. As derived from the West African food-composition table (24) , weights were assigned to these frequencies according to the content of retinol activity equivalents (mg/100 g) of the specific food item as follows: carrot 3 0.713, tomato 3 0.064, pepper 3 0.211, green leafy vegetables 3 0.387, yam 3 0.002, sweet potato 3 0.253, orange 3 0.008, papaya 3 0.080, mango 3 0.393, fish 3 0.020, red meat 3 0.040, poultry 3 0.008, milk 3 0.033, eggs 3 0.150, and palm oil 3 5.720.
Descriptive characteristics of the study population were compared between participants with T2D only, hypertension only, T2D plus hypertension, and those who were free of these conditions (controls). For continuous variables, means and SDs are presented for normally distributed variables and t tests were applied; medians and IQRs are shown for skewed data and Wilcoxon's rank-sum test was used. For categorical variables, the percentage and number of individuals are given and the chisquare test was applied. Bonferroni correction was used to adjust for multiple comparisons. To analyze the correlation structure of the biomarkers of vitamin A status, kidney function, and inflammation, we applied nonparametric Spearman correlations.
For the associations of T2D and hypertension with serum retinol concentrations, we calculated b coefficients and 95% CIs by linear regression, modeling ln-transformed retinol as the outcome variable and the following exposures: 1) T2D (yes vs. no), 2) hypertension (yes vs. no), and 3) T2D-only, hypertensiononly, T2D plus hypertension (controls = reference). In a first model, we adjusted for age and sex. A multivariate model additionally included educational attainment (no formal education vs. any), unemployment (no occupation vs. any), BMI, waist-to-hip ratio, smoking status (never vs. quit/current), weighted intake of vitamin A-rich foods (frequency/d), energy provided by fat (%), triglycerides (mmol/L), and intake of lipid-lowering drugs (yes vs. no). We calculated the proportions of the explained variance of ln(retinol) by the exposures of interest (semipartial R 2 ). All models were conducted for the complete study population and separately for women and men. Because we did not observe any differences between women and men, we herein present results of the total study population.
Finally, we applied the Baron and Kenny method (25) to evaluate whether or not RBP4, prealbumin, eGFR, urinary albumin, or CRP mediates the associations of T2D and/or hypertension with retinol concentrations-that is, the contribution of these factors to an association of T2D or hypertension with retinol concentrations. This method tests 4 paths in 3 regression analyses: 1) the independent variable (T2D and/or hypertension) is associated with the mediator (RBP4, prealbumin, eGFR, urinary albumin, or CRP); 2) the independent variable (T2D and/or hypertension) is associated with the dependent variable [ln (retinol)]; and 3) the mediator (RBP4, prealbumin, eGFR, urinary albumin, or CRP) is associated with the dependent variable [ln (retinol)], adjusted for the independent variable. In the latter, the degree of association between the independent variable (T2D and/or hypertension) and the dependent variable [ln(retinol)] will be lower than in the model excluding the mediator variable. The Sobel test was applied to estimate whether this effect change was not equal to zero (P value for mediation) and to calculate the amount of the explained variance of ln(retinol) by the independent variable accounted for by the mediator variable (% mediated) (26) .
All statistical analyses were performed by using SAS statistical software (version 9.2; SAS Institute). Significance was defined as 2-sided P values ,0.05. For the Sobel test, we used the program written by Dudley et al. (27) .
RESULTS
Study population
The study population was predominantly female (75%), middleaged (mean 6 SD age: 50.6 6 15.1 y), overweight (mean 6 SD BMI: 25.8 6 5.2), and of low socioeconomic status (lack of formal education: 25%; unemployed: 26%); 44% had T2D and 57% presented with hypertension. Participants with T2D and/or hypertension were older, heavier, and more frequently had no formal education, and were more often unemployed than controls ( Table  1) . The median (IQR) self-reported duration of T2D was 5.0 (2.0-9.0) y and for hypertension it was 4.0 (1.0-10.0) y. Almost all patients with T2D (534 of 537) received medicinal treatment, whereas this value was 71% (493 of 694) for the hypertension group. Metformin-based therapies (78%) and sulfonylurea combinations (61%) were predominant among patients with T2D (14) . Antihypertensive medications included calcium channel blockers (60%), angiotensin-converting enzyme (ACE) inhibitors (37%), diuretics (16%), and b-blockers (9%). Two percent of the study population were taking lipid-lowering drugs, with a greater proportion in the hypertension group than in the T2D group (Table 1) . The median (IQR) retinol activity equivalent-weighted intake frequency of vitamin A-rich foods was 1.64 (0.88-2.36) times/wk, Comparisons were made with the control group by applying the chi-square test for categorical variables, the t test for normally distributed continuous variables, and the Wilcoxon's rank-sum test for nonnormally distributed continuous variables. *Significant after Bonferroni correction, 2-sided P , 0.05/63 tests ,0.0008. CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; RBP4, retinol-binding protein 4; WHR, waist-to-hip ratio. Median; IQR in parentheses (all such values). 4 Calculated as the daily intake frequency of vitamin A-rich foods (from a food-frequency questionnaire) 3 food-specific retinol activity equivalents (mg/100 g food).
and the median (IQR) contribution of total fat to energy intake was 30.7% (22.6-40.8%) of energy. The intakes of vitamin A-rich foods and of fat were similar across the groups (Table 1) .
VAD, kidney dysfunction, and inflammation
Of our study population, 10% exhibited VAD (retinol ,1.05 mmol/L). Figure 2 shows the vitamin A status according to serum retinol concentrations in 1219 urban Ghanaians. Compared with controls, participants with hypertension only and those with T2D plus hypertension showed significantly lower proportions of VAD (Figure 2) . Overall, the median (IQR) concentrations were as follows: retinol, 1.6 (1.3-1.9) mmol/L; RBP4, 1.7 (1.3-2.2) mmol/L; and prealbumin, 3.2 (2.5-4.0) mmol/L. These values were higher in participants with T2D plus hypertension than in controls. This was only partially true for the groups with T2D only and with hypertension only (Table 1) . Albuminuria was present in 30%, reduced eGFR in 7%, and increased CRP in 23% of the study population. In each hypertension group, the values were higher for urinary albumin and CRP and lower for eGFR than in controls. However, this was not observed in participants with T2D only (Table 1) .
There were significant correlations between retinol, RBP4, and prealbumin, which ranged between 0.46 and 0.69 ( Table 2) . Their correlations with markers of kidney function and inflammation were weaker: urinary albumin correlated positively; eGFR and CRP showed negative correlations, the latter partially being nonsignificant. Moreover, correlations were weak for urinary albumin with eGFR (20.10), for CRP with urinary albumin (0.14), and for CRP with eGFR (20.12) ( Table 2) .
Associations of T2D and hypertension with retinol
In the linear regression analysis, we modeled ln-transformed retinol as the outcome variable and T2D and hypertension as the exposure variables. The results are presented in Table 3 . T2D (yes vs. no) was associated with higher retinol concentrations in the age-and sex-adjusted model (b: 0.063; semipartial R 2 : 0.007). This association was attenuated after the inclusion of socioeconomic, anthropometric, and behavioral variables and hypertension status. For hypertension (yes vs. no) as the exposure variable, we observed a significant positive association with retinol, which remained in the multivariate model as well as after adjustment for T2D (b: 0.124; semipartial R 2 : 0.022); intake of ACE inhibitors (b: 0.100; semipartial R 2 : 0.013); and different adjustment methods for the intake of vitamin A-rich foods.
In the next step, the control group served as the reference category to compare with T2D only, hypertension only, and T2D plus hypertension as the exposures (Table 3) . For T2D only, the associations with retinol concentration were positive but not significant (age-and sex-adjusted b: 0.050; multivariate b: 0.013). With respect to hypertension only, the significant positive association remained stable in the multivariate model (multivariate adjusted b: 0.11). For T2D plus hypertension, we observed the strongest positive association with retinol concentrations, which held true after multiple adjustments (multivariate-adjusted b: 0.16).
Finally, we evaluated whether or not vitamin A-transport proteins and markers of kidney function and inflammation mediate the associations of T2D and/or hypertension with retinol concentrations. As shown in Table 3 , the associations of T2D, irrespective of hypertension status and of isolated T2D, with ln(retinol) were weak and not significant in the multivariate model. Therefore, we did not consider these for mediation analyses. Table 4 presents the results of the mediation analysis for the associations of hypertension with ln(retinol). After the separate inclusion of each mediator variable in the multivariate model, the association of hypertension (yes vs. no) was attenuated. For instance, the inclusion of RBP4 reduced the b for hypertension from 0.12 to 0.07. This attenuation was discernible in patients with hypertension only and in those with hypertension plus T2D. The contributions of RBP4 and prealbumin to the effect of increased retinol in individuals with hypertension were 72% and 22%, respectively. Impaired kidney function assessed by eGFR and urinary albumin significantly accounted for 30% and 5% of the association between hypertension and retinol (Table 4) . Serum CRP did not substantially contribute to increased retinol concentrations in individuals with hypertension (mediated 7.5%; P-mediation = 0.09). This was similarly observed for isolated hypertension (mediated 6.3%; P-mediation = 0.4) and hypertension with concomitant T2D (mediated 3.7%; P-mediation = 0.4) ( Table 4) .
DISCUSSION
Sub-Saharan Africa is facing a double burden of malnutrition, which led us to investigate the associations of T2D and hypertension with serum retinol in urban Ghana and the importance of eGFR, urinary albumin, and CRP in these associations. In participants with hypertension, VAD, which was assessed by serum retinol, was underestimated. Impaired kidney function in these patients, as reflected by eGFR and urinary albumin but not inflammation, was the major determinant of this misclassification.
The overall proportion of VAD (10%) in our study population is comparable to figures in other low-income countries (1). In Caucasian patients with T2D, kidney function is a major determinant for serum retinol concentration (12) . In Africa, our study is the first, to our knowledge, that observed higher serum retinol concentrations and less VAD in patients with T2D and hypertension. This was discernible despite similar intake of vitamin A-rich foods and multivariate adjustments. Yet, this was less evident for T2D.
Incidentally, normal or even lower serum retinol in individuals with T2D or hypertension has been reported from the northern hemisphere (28) (29) (30) (31) (32) . In our study, the lack of impact of FIGURE 2 Vitamin A status according to serum retinol concentrations (in mmol/L) in 1219 urban Ghanaians. Controls, n = 328; type 2 diabetes only, n = 197; hypertension only, n = 354; type 2 diabetes plus hypertension, n = 340. *Different from the control group (chi-square test after Bonferroni correction; 2-sided P , 0.05/9 tests ,0.006).
inflammation on retinol concentrations seems to contradict the potential misclassification of vitamin A status observed in NHANES III (33) . Yet, in that population, the underestimation of VAD was not related to hypertension. In fact, the weak correlations of retinol, RBP4, and prealbumin with CRP in our study suggest that other factors involved in protein biosynthesis, and thus availability of RBP4 and prealbumin, contribute to the homeostasis of serum retinol in sub-Saharan Africa (34) .
Other than eGFR and urinary albumin, the strongest mediators for the association of hypertension with retinol were RBP4 and prealbumin. As reflected by the negative correlations of RBP4 and prealbumin with eGFR, the metabolism of both transport proteins is affected by kidney dysfunction. Therefore, renal retention of retinol-RBP4-prealbumin in long-lasting T2D or hypertension seems to be one plausible explanation. In fact, the average histories of T2D and hypertension in our study population were 4 and 5 y, respectively. In addition, the strong positive correlations between retinol, RBP4, and prealbumin show the physiologic formation of their large protein complex (76 kDa) (20) . Apart from the random error in biomarker measurements, the imperfect correlations of RBP4 and prealbumin most likely result from the RBP4-independent secretion of prealbumin. Indeed, .90% of circulating RBP4 is linked to prealbumin, but only 40% of prealbumin is in complex with RBP4 (35) . In addition, retained apo-RBP4 (retinolfree RBP4) in kidney dysfunction constitutes a signaling factor for hepatic release of retinol, and it may lead to increased serum retinol (9, 36) . Admittedly, insulin-sensitizing therapies, particularly sulfonylureas (37), antihypertensive medication, particularly ACE inhibitors (38) , and lipid-lowering drugs, affect insulin secretion and action. Because insulin is known to influence hepatic retinol metabolism (39) , these therapeutic interventions may represent potential confounders. Yet, .99% of the T2D cases in our study population were receiving medicinal treatment for a median of 5 years, with only 2% taking lipid-lowering drugs. Also, the associations with hypertension remained after adjustment for ACE inhibitors.
Still, reduced glomerular filtration of the retinol-RBP4 complex and the limited conversion of retinol to retinal are the main drivers for high serum retinol (35) . In a cohort study in Tunisia, patients with end-stage renal disease had higher serum retinol at baseline than did healthy individuals (40) . In addition, in 1177 German hemodialysis patients with T2D, alterations in vitamin A metabolism were associated with kidney dysfunction (41) . Elevated retinol concentrations were also discernible in Israel among patients with chronic renal failure, in whom water-soluble retinyl-glucuronide and retinoyl-glucoronide might accumulate (42) . Yet, the formation of retinol from these substances among individuals with T2D or hypertension is unclear.
Our findings may have substantial public health implications for sub-Saharan Africa. In resource-poor settings, a cost-effective and valid biomarker for the detection of VAD is essential for vitamin A supplementation, fortification, and surveillance. Underestimation of VAD in patients with T2D, hypertension, and other diseases associated with kidney dysfunction may thus Model 2 with the exposure variable hypertension adjusted for type 2 diabetes, age, sex, educational attainment, unemployment, BMI, waist-to-hip ratio, smoking status, vitamin A-rich foods, percentage of energy from fat, triglycerides, and lipid-lowering drugs. 4 Model 3 with the exposure variables type 2 diabetes only, hypertension only, and type 2 diabetes plus hypertension adjusted for age, sex, educational attainment, unemployment, BMI, waist-to-hip ratio, smoking status, vitamin A-rich foods, percentage of energy from fat, triglycerides, and lipid-lowering drugs. complicate such programs. The most vulnerable groups to micronutrient deficiencies are young children, pregnant women, and women of child-bearing age, with the latter forming at least one-third of our study population. As an example, for iron deficiency in individuals with inflammation, specific cutoffs were proposed in combining iron markers with CRP (43) (44) (45) (46) . Adjusted cut-offs shows one possibility to avoid false-negative diagnosis of VAD and harmful vitamin supplementation in Africa. Similarly, specific weights may be assigned to serum retinol as a marker for VAD in patients with T2D and hypertension. However, further information on the bioavailability of retinol in these individuals is needed to establish respective cutoffs or weighting factors.
In sub-Saharan Africa, this is a unique study that covers a comparatively large sample size. Although the case-control design is useful for hypothesis building, we also acknowledge the potential of reverse causation. This applies to kidney dysfunction, which can cause hypertension, and to RBP4 as a risk factor for T2D and its complications. Indeed, several cross-sectional and some longitudinal studies have examined the latter. Although RBP4 contributes to insulin resistance, obesity, and dyslipidemia in some populations (47) , its metabolic effect is not clear in others (48) . However, retinol concentrations have hardly been considered in these investigations (29, 31, 32) , and RBP4 as a risk factor for T2D requires verification in African populations.
In addition, for ethical reasons, we did not assess the degree of hepatic vitamin A storage as the gold standard for vitamin A status. Future studies should account for liver function and thus repletion of hepatic vitamin A storage as a potential confounder. Similarly, we cannot exclude the role of (pro-)vitamin A storage in subcutaneous and visceral adipose tissues. However, in our analysis and as surrogates, we adjusted for general and abdominal obesity measures. At the same time, even in extremely obese individuals, the contribution of mobilized vitamin A from various adipose tissues to circulating retinol is supposed to be rather low and has not been investigated in detail. Also, we minimized the potential overrating of our estimates due to differential intake of vitamin A by adjusting for the intake of vitamin A-rich foods. In our study, T2D and hypertension were related to age, body fatness, socioeconomic status, and other risk factors. Although we accounted for these differences in multivariate regression models, residual confounding cannot fully be excluded. The definitions of T2D and hypertension were based on single measurements and documented medications. This is suboptimal compared with use of an oral-glucose-tolerance test, glycated hemoglobin, and 24-h blood pressure and might have overestimated cases with T2D and hypertension. However, most of these patients had been known to the hospital for years and their medical history was well documented. In addition, single measurements combined with medications as definition criteria follow the general practice in resource-poor settings, whereas the interpretation of glycated hemoglobin in Africa is complicated by the high prevalences of hemoglobinopathies and hemolytic diseases (49) . The generalizability of our findings may be questionable, because the controls recruited among hospital patients were not representative of the general Ghanaian population. However, the higher proportions of diseases and drug intake in the control group than in the general population made the relations between T2D, hypertension, and retinol appear weaker than they truly are.
In conclusion, individuals with long-lasting T2D or hypertension were characterized by increased serum retinol concentrations, which were mainly attributed to reduced kidney function and led to an underestimation of VAD in an urban Ghanaian population. This potential misclassification of vitamin A status may have important consequences for supplementation programs, food fortification, and disease monitoring in this area with a growing burden of T2D and hypertension.
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